Rhythm Pharmaceuticals (RYTM) has an average rating of Buy and mean price target of $138.80, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
UBS on Friday downgraded Swiss precision components and fastening technology company SFS Group (SFSN.SW) to neutral from buy and increased its price target to 145 francs from 130 francs.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
BNP Paribas on Friday downgraded building materials company Wienerberger (WIBA.F) to neutral from outperform and reduced its price target to 20 euros from 27 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
AlphaValue/Baader Europe on Friday upgraded British events, digital services, and academic research group Informa (INF.L) to buy from add and raised its price target to 11.56 pounds sterling from 11.46 pounds.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)